Correlation Between C4 TherapeuticsInc and SCOR PK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both C4 TherapeuticsInc and SCOR PK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 TherapeuticsInc and SCOR PK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 TherapeuticsInc and SCOR PK, you can compare the effects of market volatilities on C4 TherapeuticsInc and SCOR PK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 TherapeuticsInc with a short position of SCOR PK. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 TherapeuticsInc and SCOR PK.

Diversification Opportunities for C4 TherapeuticsInc and SCOR PK

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between CCCC and SCOR is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding C4 TherapeuticsInc and SCOR PK in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCOR PK and C4 TherapeuticsInc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 TherapeuticsInc are associated (or correlated) with SCOR PK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCOR PK has no effect on the direction of C4 TherapeuticsInc i.e., C4 TherapeuticsInc and SCOR PK go up and down completely randomly.

Pair Corralation between C4 TherapeuticsInc and SCOR PK

Given the investment horizon of 90 days C4 TherapeuticsInc is expected to under-perform the SCOR PK. In addition to that, C4 TherapeuticsInc is 1.34 times more volatile than SCOR PK. It trades about -0.37 of its total potential returns per unit of risk. SCOR PK is currently generating about -0.03 per unit of volatility. If you would invest  332.00  in SCOR PK on January 30, 2024 and sell it today you would lose (6.00) from holding SCOR PK or give up 1.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

C4 TherapeuticsInc  vs.  SCOR PK

 Performance 
       Timeline  
C4 TherapeuticsInc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in C4 TherapeuticsInc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, C4 TherapeuticsInc exhibited solid returns over the last few months and may actually be approaching a breakup point.
SCOR PK 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in SCOR PK are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, SCOR PK may actually be approaching a critical reversion point that can send shares even higher in May 2024.

C4 TherapeuticsInc and SCOR PK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with C4 TherapeuticsInc and SCOR PK

The main advantage of trading using opposite C4 TherapeuticsInc and SCOR PK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 TherapeuticsInc position performs unexpectedly, SCOR PK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCOR PK will offset losses from the drop in SCOR PK's long position.
The idea behind C4 TherapeuticsInc and SCOR PK pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals